Brief: Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy With Prosomnus Devices Is Non-Inferior To Cpap Therapy For The Treatment Of Moderate To Severe Obstructive Sleep Apnea
Aug 23 (Reuters) -
* UPDATED CLINICAL TRIAL DATA INDICATES PRECISION ORAL
APPLIANCE
THERAPY WITH PROSOMNUS DEVICES IS NON-INFERIOR TO CPAP THERAPY
FOR THE TREATMENT OF MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA
* PROSOMNUS INC - FIRST LINE OBSTRUCTIVE SLEEP APNEA
TREATMENT
STUDY (FLOSAT) IS ON TRACK TO ACHIEVE ALL ENDPOINTS
* PROSOMNUS INC - PATIENTS ARE ACTIVELY BEING ENROLLED IN
SEVERE
OSA STUDY
* PROSOMNUS INC - RESULTS OF STUDY INDICATE THAT PRECISION
OAT
WITH PROSOMNUS DEVICES IS AN EFFECTIVE, AND PREFERRED, OPTION
FOR PATIENTS
Source text for Eikon: ID:nGNXbnWpQ4
Further company coverage: OSA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on ProSomnus
See all newsBrief: Prosomnus Sleep Technologies Says Co Enters Into Voluntary Chapter 11 Restructuring Process Which Will Take Company Private, Reduce Debt
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Prosomnus Raises $10 Million To Fuel Growth And Optimize Operations
Brief: Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy With Prosomnus Devices Is Non-Inferior To Cpap Therapy For The Treatment Of Moderate To Severe Obstructive Sleep Apnea